tripelennamine has been researched along with Glomerulosclerosis, Focal Segmental in 1 studies
Tripelennamine: A histamine H1 antagonist with low sedative action but frequent gastrointestinal irritation. It is used to treat ASTHMA; HAY FEVER; URTICARIA; and RHINITIS; and also in veterinary applications. Tripelennamine is administered by various routes, including topically.
Glomerulosclerosis, Focal Segmental: A clinicopathological syndrome or diagnostic term for a type of glomerular injury that has multiple causes, primary or secondary. Clinical features include PROTEINURIA, reduced GLOMERULAR FILTRATION RATE, and EDEMA. Kidney biopsy initially indicates focal segmental glomerular consolidation (hyalinosis) or scarring which can progress to globally sclerotic glomeruli leading to eventual KIDNEY FAILURE.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| May, DC | 1 |
| Helderman, JH | 1 |
| Eigenbrodt, EH | 1 |
| Silva, FG | 1 |
1 other study available for tripelennamine and Glomerulosclerosis, Focal Segmental
| Article | Year |
|---|---|
Chronic sclerosing glomerulopathy (heroin-associated nephropathy) in intravenous T's and Blues abusers.
Topics: Adult; Biopsy; Glomerulonephritis; Glomerulosclerosis, Focal Segmental; Heroin Dependence; Humans; I | 1986 |